|Title:||Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels|
|Abstract:||Testosterone is administered transdermally through nonscrotal skin in a manner that mimics in amount and profile the natural production of testosterone in young adult healthy males. The testosterone is administered to the skin from a matrix which contains testosterone at subsaturation concentration and a permeation enhancer.|
|Inventor(s):||Ebert; Charles D. (Salt Lake City, UT), Patel; Dinesh (Murray, UT), Heiber; Werner (Salt Lake City, UT)|
|Assignee:||Theratech, Inc. (Salt Lake City, UT)|
Patent Claim Types:|
see list of patent claims
|Device; Composition; Use;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.